drugset / Trial / NCT01124162

Losartan 100 mg Tablets in Healthy Subjects Under Fasting Conditions

NCT01124162

Phase 1 Completed 80 enrolled Teva Pharmaceuticals USA
RandomizedCrossoverOpen-label

Summary

The objective of this study is to compare the rate and extent of absorption of losartan 100 mg tablets (test) versus Cozaar® (reference), administered as 1 \* 100 mg tablet under fasting conditions.

Timeline

Start
2003-10
Primary completion
2003-11
Completion
2003-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Losartan Other / unclassified 100 mg

Indications

No indication recorded.